Shenghua Zhang

2.8k total citations
105 papers, 2.1k citations indexed

About

Shenghua Zhang is a scholar working on Molecular Biology, Oncology and Plant Science. According to data from OpenAlex, Shenghua Zhang has authored 105 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 25 papers in Oncology and 14 papers in Plant Science. Recurrent topics in Shenghua Zhang's work include Cancer therapeutics and mechanisms (9 papers), Peptidase Inhibition and Analysis (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Shenghua Zhang is often cited by papers focused on Cancer therapeutics and mechanisms (9 papers), Peptidase Inhibition and Analysis (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Shenghua Zhang collaborates with scholars based in China, United States and Hong Kong. Shenghua Zhang's co-authors include Yong‐Su Zhen, Rong‐Guang Shao, Yirong Wang, Yifeng Zhou, Siqi Wu, Jieqiong Deng, Xun Zhu, Binbin Guo, Hongwei He and Dandan Ren and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The EMBO Journal.

In The Last Decade

Shenghua Zhang

103 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shenghua Zhang China 26 1.1k 440 387 333 207 105 2.1k
Antonella D’Anneo Italy 29 1.3k 1.1× 443 1.0× 198 0.5× 362 1.1× 130 0.6× 74 2.2k
Chandrasekharan Guruvayoorappan India 23 1.0k 0.9× 260 0.6× 265 0.7× 319 1.0× 309 1.5× 73 2.2k
Hui‐Fen Liao Taiwan 27 1.0k 0.9× 430 1.0× 218 0.6× 211 0.6× 157 0.8× 79 2.1k
Shanshan Zhang China 22 947 0.8× 336 0.8× 321 0.8× 221 0.7× 182 0.9× 85 1.9k
Young‐Rae Lee South Korea 27 1.0k 0.9× 342 0.8× 215 0.6× 215 0.6× 278 1.3× 81 2.1k
Jinhui Zhang China 23 931 0.8× 346 0.8× 296 0.8× 179 0.5× 117 0.6× 98 2.0k
Marianna Lauricella Italy 28 1.3k 1.2× 379 0.9× 182 0.5× 311 0.9× 118 0.6× 80 2.1k
Yanna Cheng China 29 933 0.8× 218 0.5× 238 0.6× 266 0.8× 183 0.9× 66 2.0k
Hwan Mook Kim South Korea 31 1.1k 1.0× 274 0.6× 399 1.0× 277 0.8× 399 1.9× 89 2.4k
Hongzhi Du China 25 882 0.8× 265 0.6× 293 0.8× 217 0.7× 120 0.6× 75 1.8k

Countries citing papers authored by Shenghua Zhang

Since Specialization
Citations

This map shows the geographic impact of Shenghua Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenghua Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenghua Zhang more than expected).

Fields of papers citing papers by Shenghua Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenghua Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenghua Zhang. The network helps show where Shenghua Zhang may publish in the future.

Co-authorship network of co-authors of Shenghua Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Shenghua Zhang. A scholar is included among the top collaborators of Shenghua Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenghua Zhang. Shenghua Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Lili, et al.. (2025). Nutritional management of chronic kidney disease in children: a best evidence summary. International Urology and Nephrology. 58(4). 1393–1407. 1 indexed citations
2.
Liu, Tengfei, Kai Zhang, Zicheng Xu, et al.. (2025). Lead toxicity in Nicotiana tabacum L.: Damage antioxidant system and disturb plant metabolism. Ecotoxicology and Environmental Safety. 291. 117837–117837. 5 indexed citations
3.
Zhang, Zheng, Fanrong Li, Yirong Wang, et al.. (2024). A novel micropeptide miPEP205 suppresses the growth and metastasis of TNBC. Oncogene. 44(8). 513–529. 4 indexed citations
4.
Zhang, Shenghua, Jian Zheng, Yirong Wang, et al.. (2023). LncRNA-Encoded Micropeptide ACLY-BP Drives Lipid Deposition and Cell Proliferation in Clear Cell Renal Cell Carcinoma via Maintenance of ACLY Acetylation. Molecular Cancer Research. 21(10). 1064–1078. 18 indexed citations
5.
Zhu, Zhu, et al.. (2021). Macrophage-Derived Immunoglobulin M Inhibits Inflammatory Responses via Modulating Endoplasmic Reticulum Stress. Cells. 10(11). 2812–2812. 7 indexed citations
6.
Guo, Binbin, Siqi Wu, Xun Zhu, et al.. (2019). Micropeptide CIP 2A‐ BP encoded by LINC 00665 inhibits triple‐negative breast cancer progression. The EMBO Journal. 39(1). e102190–e102190. 194 indexed citations
7.
Wang, Yirong, Siqi Wu, Xun Zhu, et al.. (2019). LncRNA-encoded polypeptide ASRPS inhibits triple-negative breast cancer angiogenesis. The Journal of Experimental Medicine. 217(3). 177 indexed citations
8.
Wang, Yangyang, Liang Li, Yi Li, et al.. (2018). A Macropinocytosis-Intensifying Albumin Domain-Based scFv Antibody and Its Conjugate Directed against K-Ras Mutant Pancreatic Cancer. Molecular Pharmaceutics. 15(6). 2403–2412. 25 indexed citations
9.
Xu, Jian, Xiujun Liu, Liang Li, et al.. (2015). An engineered TIMP2-based and enediyne-integrated fusion protein for targeting MMP-14 shows potent antitumor efficacy. Oncotarget. 6(28). 26322–26334. 20 indexed citations
10.
Guo, Xiaofang, Xiaofei Zhu, Yue Shang, Shenghua Zhang, & Yong‐Su Zhen. (2010). A Bispecific Enediyne-Energized Fusion Protein Containing Ligand-Based and Antibody-Based Oligopeptides against Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2 Shows Potent Antitumor Activity. Clinical Cancer Research. 16(7). 2085–2094. 38 indexed citations
11.
Zhu, Caiping & Shenghua Zhang. (2009). Extraction and composition of Lycium barbarum polysaccharide by GC.. Xiandai shipin keji. 25(11). 1327–1334. 1 indexed citations
12.
Zhang, Shenghua. (2006). Study on Antitumor Inhibition of Soyasaponins on Hepatocarcinoma H_(22) Mice. Food Science. 1 indexed citations
13.
Zhang, Shenghua. (2005). Effect of Lovastatin from Red Kojic on lipid metabolism and expression of lipoprotein lipase mRNA in hyperlipidemic mice. Zhongcaoyao. 1 indexed citations
14.
Zhang, Shenghua. (2005). Effects of Lycium barbarum Polysaccharides on Serum Lipids and Lipid Peroxidation in Hyperlipidemic Mice. Acta Nutrimenta Sinica. 6 indexed citations
15.
Zhang, Shenghua. (2004). Effect of MRPI Extracted from Red Kojic on Lipid Metabolism in Mouse. Food Science. 1 indexed citations
16.
Zhang, Shenghua. (2004). Hyperglycemia Lowering Effect of Soybean Isoflavone(SI) on Alloxan-induced Diabetic Mice. Food Science. 2 indexed citations
17.
Wang, Jianhua, Min Zhang, Lu Gan, & Shenghua Zhang. (2001). Study on scavenging effect of lycium barbarum polysacch aride-2 on the oxidation induced by hydroxyl radicals. Food Science. 22(1). 11–13. 6 indexed citations
18.
Liang, Fuyou, et al.. (1999). Use of monoclonal antibody norcantharidin conjugate in experimental targeting therapy of tumor. Dongwuxue zazhi. 34(2). 18–22. 1 indexed citations
19.
Zhang, Shenghua, et al.. (1998). Separation and identification of carotenoids in fructus lycii by thin-layer chromatography. 20(1). 76–78. 7 indexed citations
20.
Zhang, Shenghua, et al.. (1996). Isolation and composition of Lycium barbarum polysaccharides. 31(12). 716–720. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026